{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T03:25:38Z","timestamp":1787109938920,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":4401,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.anpedi.2013.10.027","type":"journal-article","created":{"date-parts":[[2013,11,16]],"date-time":"2013-11-16T23:45:51Z","timestamp":1384645551000},"page":"77-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Vigilancia pasiva de la seguridad postautorizaci\u00f3n de las vacunas frente a rotavirus: sensibilidad de la notificaci\u00f3n de invaginaci\u00f3n intestinal"],"prefix":"10.1016","volume":"81","author":[{"given":"S.","family":"P\u00e9rez-Vilar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"D\u00edez-Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gomar-Fayos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Pastor-Villalba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sastre-Cant\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Puig-Barber\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2013.10.027_bib0005","first-page":"1007","article-title":"Withdrawal of rotavirus vaccine, recommendation","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly, Rep"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0010","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00006454-200104000-00008","article-title":"Population-based study of rotavirus vaccination and intussusception","volume":"20","author":"Kramarz","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0015","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM200102223440804","article-title":"Intussusception among infants given an oral rotavirus vaccine","volume":"344","author":"Murphy","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0020","first-page":"577","article-title":"Intussusception among recipients of rotavirus vaccine--United States, 1998-1999","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0025","unstructured":"Rotarix: Product Information European Medicines Agency (EMA); 2013 [actualizado 3 May 2013; citado 4 Jun 2013]. Disponible en: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000639\/human_med_001043.jsp&mid=WC0b01ac058001d124"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0030","unstructured":"RotaTeq. Product information. European Medicines Agency (EMA); 2013 [actualizado 17 Abr 2013; citado 4 Jun 2013]. Disponible en: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000669\/human_med_001045.jsp&mid=WC0b01ac058001d124"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0035","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS). Nota para profesionales sanitarios. Actualizaci\u00f3n de la informaci\u00f3n sobre la detecci\u00f3n de ADN de circovirus porcino (PCV-1) en la vacuna frente a rotavirus Rotarix\u00ae. 2010 [citado 3 Jun 2013]. Disponible en: http:\/\/www.aemps.gob.es\/informa\/notasInformativas\/medicamentosUsoHumano\/calidad\/2010\/NI-circovirus_julio-2010.htm"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0040","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS). Nota informativa para profesionales sanitarios. Detecci\u00f3n de ADN de circovirus porcino tipo 1 y 2 (PCV-1 Y PCV-2) en la vacuna frente a rotavirus RotaTeq\u00ae. 2010 [citado 3 Jun 2013]. Disponible en: http:\/\/www.aemps.gob.es\/informa\/notasInformativas\/medicamentosUsoHumano\/calidad\/2010\/NI-circovirus-rotateq_junio-2010.htm"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0045","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS). Nota informativa: Liberaci\u00f3n de lotes de la vacuna Rotateq. 2010 [citado 3 Jun 2013]. Disponible en: http:\/\/www.aemps.gob.es\/informa\/notasInformativas\/medicamentosUsoHumano\/calidad\/2010\/NI-circovirus-rotateq_noviembre-2010.htm"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0050","unstructured":"RotaTeq. Assessment history. CHMP post-authorisation summary of positive opinion for RotaTeq. European Medicines Agency (EMA); 2012 [actualizado 20 Ene 2012;; citado 26 Agos 2013]. Disponible en: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000669\/human_med_001045.jsp&mid=WC0b01ac058001d124"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0055","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa1012952","article-title":"Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil","volume":"364","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0060","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.vaccine.2011.01.088","article-title":"Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia","volume":"29","author":"Buttery","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0065","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1542\/peds.2007-3793","article-title":"Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007","volume":"121","author":"Haber","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/INF.0b013e3181af8605","article-title":"Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine","volume":"29","author":"Belongia","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0075","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/jama.2012.97","article-title":"Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants","volume":"307","author":"Shui","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/infdis\/jis314","article-title":"Trends in intussusception hospitalizations among US infants before and after implementation of the rotavirus vaccination program, 2000-2009","volume":"206","author":"Yen","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0085","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archpediatrics.2011.1501","article-title":"Hospitalizations for intussusception before and after the reintroduction of rotavirus vaccine in the United States","volume":"166","author":"Zickafoose","year":"2012","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0090","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1542\/peds.2012-2554","article-title":"Intussusception after rotavirus vaccines reported to US VAERS, 2006-2012","volume":"131","author":"Haber","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0095","unstructured":"U.S. Food and Drug Administration (FDA). FDA releases final study results of a mini-sentinel postlicensure observational study of rotavirus vaccines and intussusception. 2013 [citado 19 Jun 2013; FDA Safety Communication]. Disponible en: http:\/\/www.fda.gov\/BiologicsBloodVaccines\/SafetyAvailability\/ucm356758.htm"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0100","doi-asserted-by":"crossref","unstructured":"Carlin JB, Macartney KK, Lee KJ, Quinn HE, Buttery J, Lopert R, et al. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program. Clin Infect Dis. 2013;57:1427-34.","DOI":"10.1093\/cid\/cit520"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0105","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2105\/AJPH.85.12.1706","article-title":"The reporting sensitivities of two passive surveillance systems for vaccine adverse events","volume":"85","author":"Rosenthal","year":"1995","journal-title":"Am J Public Health"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0110","series-title":"Advances in inflammation research","first-page":"1","article-title":"Epidemiology of adverse reactions to nonsteroidal antiinflammatory drugs","author":"Weber","year":"1984"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0115","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006454-200404000-00002","article-title":"Understanding vaccine safety information from the Vaccine Adverse Event Reporting System","volume":"23","author":"Varricchio","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0120","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS). Notificaci\u00f3n electr\u00f3nica de sospechas de reacciones adversas a medicamentos por los ciudadanos. Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS); 2013 [citado 3 Jun 2013]. Disponible en: http:\/\/www.aemps.gob.es\/informa\/notasInformativas\/medicamentosUsoHumano\/seguridad\/ciudadanos\/2013\/NI-MUH_FV_03-2013-notifica-ram.htm"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0125","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS). \u00bfQu\u00e9 es el Sistema Espa\u00f1ol de Farmacovigilancia de medicamentos de uso humano? 2013 [citado 3 Jun 2013]. Disponible en: http:\/\/www.aemps.gob.es\/vigilancia\/medicamentosUsoHumano\/SEFV-H\/home.htm"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0130","unstructured":"Orden 16\/2010, de 17 de noviembre, de la Conselleria de Sanidad, por la que se regula la farmacovigilancia de medicamentos de uso humano en la Comunitat Valenciana (2010)."},{"key":"10.1016\/j.anpedi.2013.10.027_bib0135","unstructured":"Pastor-Villalba E, Mart\u00edn-Ivorra R, Alguacil-Ramos A, Barber\u00e1-Catal\u00e1 M, Pons-S\u00e1nchez C, Lluch Rodrigo J. Sistema de Informaci\u00f3n Vacunal (SIV). Valencia: Conselleria de Sanitat. Generalitat Valenciana; 2009. [citado 3 Jun 2013]. Disponible en: http:\/\/www.sp.san.gva.es\/biblioteca\/publicacion_dgsp.jsp?cod_pub_ran=19281&tacc=16"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0140","unstructured":"Ministerio de Sanidad Servicios Sociales e Igualdad. Gobierno de Espa\u00f1a. Explotaci\u00f3n del registro de altas -CMBD- del Sistema Nacional de Salud. Estad\u00edsticos de referencia estatal de GRD. A\u00f1os 2000-2008 [citado 20 Agost 2013]. Disponible en: http:\/\/www.msssi.gob.es\/estadEstudios\/estadisticas\/cmbd\/informes\/home.htm"},{"issue":"5-6","key":"10.1016\/j.anpedi.2013.10.027_bib0145","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.vaccine.2003.09.016","article-title":"Acute intussusception in infants and children as an adverse event following immunization: Case definition and guidelines of data collection, analysis, and presentation","volume":"22","author":"Bines","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0150","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS). Informaci\u00f3n para las notificaciones de sospechas de reacciones adversas a medicamentos por parte de profesionales sanitarios. 2013 [citado 12 Jul 2013]. Disponible en: http:\/\/www.aemps.gob.es\/vigilancia\/medicamentosUsoHumano\/SEFV-H\/NRA-SEFV-H\/notificaSospechas-RAM-profSanitarios.htm"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0155","unstructured":"Medical dictionary for regulatory activities [citado 3 Jun 2013]. Disponible en: http:\/\/www.meddramsso.com"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0160","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/aje\/154.11.1006","article-title":"Enhancing vaccine safety surveillance: A capture-recapture analysis of intussusception after rotavirus vaccination","volume":"154","author":"Verstraeten","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0165","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/INF.0b013e3181a66471","article-title":"Kawasaki disease after vaccination: reports to the vaccine adverse event reporting system 1990-2007","volume":"28","author":"Hua","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0170","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/INF.0b013e3182421390","article-title":"Postmarketing evaluation of the short-term safety of the pentavalent rotavirus vaccine","volume":"31","author":"Loughlin","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0175","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pedhc.2007.08.013","article-title":"Supraventricular tachycardia in the pediatric primary care setting: Age-related presentation, diagnosis, and management","volume":"22","author":"Schlechte","year":"2008","journal-title":"J Pediatr Health Care"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0180","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/pds.1390","article-title":"Evaluating adverse events after vaccination in the Medicare population","volume":"16","author":"Burwen","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0185","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1542\/peds.2011-1111","article-title":"The risk of immune thrombocytopenic purpura after vaccination in children and adolescents","volume":"129","author":"O\u2019Leary","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0190","first-page":"49","article-title":"WHO position paper-January 2013","volume":"88","year":"2013","journal-title":"Wkly Epidemiol Rec."},{"issue":"Suppl 5","key":"10.1016\/j.anpedi.2013.10.027_bib0195","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1469-0691.2012.03981.x","article-title":"Rotavirus vaccination: A concise review","volume":"18","author":"Vesikari","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.anpedi.2013.10.027_bib0200","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.vaccine.2011.11.071","article-title":"Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain","volume":"30","author":"Castilla","year":"2012","journal-title":"Vaccine"}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403313004311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403313004311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:39:17Z","timestamp":1787107157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403313004311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1695403313004311"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2013.10.027","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vigilancia pasiva de la seguridad postautorizaci\u00f3n de las vacunas frente a rotavirus: sensibilidad de la notificaci\u00f3n de invaginaci\u00f3n intestinal","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2013.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}